Company: MYGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000899923-25-000019
Chunk: 48

Company: MYRIAD GENETICS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 15
Chunk 48
---
 Genetics, Inc. and HCPI/UTAH II, LLC10-Q(Exhibit 10.2)5/4/2016000-26642.3Lease Termination Agreement, dated December 18, 2023, between Myriad Genetics, Inc. and HCPI/Utah II, LLC10-K (Exhibit 10.2.3)2/28/2024000-2664210.3.1Lease Agreement, dated March 31, 2001, between the Registrant and Boyer Research Park Associates VI, by its general partner, The Boyer Company, L.C.10-Q(Exhibit 10.1)5/15/2001000-26642.2Amendment to Phase III Lease Agreement, dated February 3, 2016, between Myriad Genetics, Inc. and HCPI/UTAH II, LLC10-Q(Exhibit 10.3)5/4/2016000-26642

108

Table of Contents

ExhibitNumberExhibit DescriptionFiled with thisReportIncorporated byReference hereinfrom Form orScheduleFiling DateSEC File/RegistrationNumber.3Lease Termination Agreement, dated December 18, 2023, between Myriad Genetics, Inc. and HCPI/Utah II, LLC10-K (Exhibit 10.3.3)2/28/2024000-2664210.4.1Lease Agreement, dated February 9, 2022, between Myriad Genetics, Inc. and Bay Bridge/Corporate, LLC10-K (Exhibit 10.4)2/28/2024000-26642.2Amendment to Building D Lease Agreement, dated April 10, 2024, between Myriad Genetics, Inc. and ATP SLC D, LLCX10.5Lease, effective December 7, 2021, between Myriad Women's Health, Inc. and Bayside Area Development, LLC10-K (Exhibit 10.5)2/28/2024000-2664210.6.1Lease Agreement, dated December 1, 2012, by and between Assurex Health, Inc. and the City of Mason, OhioX.2Fifth Addendum to Lease Agreement, dated February 20, 2025, between Assurex Health, Inc. and the City of Mason, OhioXAgreements with Executive Officers and